Your browser doesn't support javascript.
loading
CAR T-Cell therapy for the management of mantle cell lymphoma.
Huang, Zoufang; Chavda, Vivek P; Bezbaruah, Rajashri; Dhamne, Hemant; Yang, Dong-Hua; Zhao, Hong-Bing.
Affiliation
  • Huang Z; Department of Hematology, Ganzhou Key Laboratory of Hematology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
  • Chavda VP; Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad, , 380009, Gujarat, India. Vivek7chavda@gmail.com.
  • Bezbaruah R; Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, India.
  • Dhamne H; Process Development, Gene Therapy Vector Facility, Research Management and Innvotations Directorate, King's College London, London, WC2R 2LS, UK.
  • Yang DH; New York College of Traditional Chinese Medicine, Mineola, NY, 11501, USA.
  • Zhao HB; Department of Oncology, the First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China. zhbzxfzzy@126.com.
Mol Cancer ; 22(1): 67, 2023 03 31.
Article in En | MEDLINE | ID: mdl-37004047
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Mantle-Cell / Receptors, Chimeric Antigen Type of study: Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Mantle-Cell / Receptors, Chimeric Antigen Type of study: Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: China